Skip to content

Impedance vs. Contact Force Guided Atrial Fibrillation Ablation Using Automated Annotation System

Comparison of Efficacy Between Impedance Guided and Contact Force Guided Atrial Fibrillation Ablation Using Automated Annotation System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02364401
Enrollment
50
Registered
2015-02-18
Start date
2015-02-28
Completion date
2016-12-15
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial Fibrillation, Catheter ablation

Brief summary

The purpose of this study is to compare the efficacy of catheter ablation for atrial fibrillation between contact force-guided and impedance-guided annotation using automated annotation system (Visitag™). Patients who receive atrial fibrillation ablation are randomly assigned in the same number to two groups with impedance guided ablation and contact force guided ablation using contact force sensing catheter (THERMOCOOL® SMARTTOUCH™ catheter, Biosense Webster, Inc., Diamond Bar, CA).

Detailed description

During atrial fibrillation ablation, the location where ablation is conducted is displayed through annotation tags using 3D system to recognize energy delivery is done at the area. However this annotation method was unable to identify how effectively the ablation is done. To remedy this disadvantage, automated annotation system (VisiTag™ module, Biosense Webster, Inc., Diamond Bar, CA) was recently developed to make an automatic annotation when all pre-defined criteria are satisfied. But study on the clinical effects of this system is insufficient. The purpose of this study is to compare the efficacy of catheter ablation for atrial fibrillation between contact force-guided and impedance-guided annotation using automated annotation system.

Interventions

DEVICEAblation

Catheter ablation for atrial fibrillation

Sponsors

Biosense Webster, Inc.
CollaboratorINDUSTRY
Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with non-valvular atrial fibrillation * Patients having atrial fibrillation even after receiving continued treatment with at least 1 antiarrhythmic drug for more than 6 weeks * Patients with tachycardia-bradycardia syndrome associated with atrial fibrillation. * Patients who can understand the information sheet and consent form on the need and procedure of catheter ablation and submitted them * Patients who are available of follow-up at least for more than three months after catheter ablation

Exclusion criteria

* Patients unsuitable for catheter ablation because the size of left atrium is over 5.5cm * Patients unsuitable for catheter ablation due to previous history of pulmonary surgery or structural heat disease. * Patients who cannot receive standard treatments such as anticoagulation therapy which need to be continuously performed prior to radiofrequency catheter ablation * Patients in the subject group vulnerable to clinical study * Patients who had undergone a prior catheter ablation for atrial fibrillation

Design outcomes

Primary

MeasureTime frameDescription
Acute success rate of pulmonary vein isolation obtained after initial circumferential ablation line around pulmonary veins6 hoursAcute success is defined as confirmation of entrance block in all pulmonary veins

Secondary

MeasureTime frame
Procedure time6 hours
Ablation time6 hours
Recurrence of any atrial arrhythmias (atrial fibrillation or atrial tachycardia)12 months
Impedance drop of each ablation lesion6 hours
Force time integral of each ablation lesion6 hours
Average contact force of each ablation lesion6 hours

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026